What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
His primary areas of study are Internal medicine, Endocrinology, Risk factor, Odds ratio and Breast cancer.
Many of his studies on Internal medicine apply to Oncology as well.
His Endocrinology study combines topics in areas such as Vitamin C and Confidence interval.
His research on Risk factor also deals with topics like
- Surgery and related Lung cancer,
- Food science that intertwine with fields like Statistical significance.
His Odds ratio research includes elements of Case-control study, Gynecology, Genotype, Physiology and Confounding.
He works mostly in the field of Breast cancer, limiting it down to topics relating to Epidemiology and, in certain cases, Public health, Incidence, Gerontology, Cohort and Binge drinking.
His most cited work include:
- American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer with Healthy Food Choices and Physical Activity (1515 citations)
- Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. (431 citations)
- Intake of Fruits and Vegetables and Risk of Breast Cancer A Pooled Analysis of Cohort Studies (422 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Breast cancer, Cancer, Endocrinology and Oncology.
Odds ratio, Prospective cohort study, Risk factor, Cohort study and Relative risk are among the areas of Internal medicine where the researcher is concentrating his efforts.
His studies in Risk factor integrate themes in fields like Quartile and Surgery.
The Breast cancer study combines topics in areas such as Epidemiology, DNA methylation, Case-control study, Gynecology and Genotype.
The study incorporates disciplines such as Immunology and Cohort in addition to Cancer.
Jo L. Freudenheim combines topics linked to Physiology with his work on Endocrinology.
He most often published in these fields:
- Internal medicine (54.67%)
- Breast cancer (41.36%)
- Cancer (26.06%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (54.67%)
- Breast cancer (41.36%)
- Cancer (26.06%)
In recent papers he was focusing on the following fields of study:
Jo L. Freudenheim focuses on Internal medicine, Breast cancer, Cancer, Oncology and Hazard ratio.
His work on Internal medicine is being expanded to include thematically relevant topics such as Gynecology.
His biological study spans a wide range of topics, including Cancer research, Methylation, Women's Health Initiative and DNA methylation.
His work deals with themes such as Electronic cigarette, Immunology, Lung, Physiology and Nicotine, which intersect with Cancer.
His research integrates issues of Endocrinology, Case-control study, Sleep in non-human animals, Ovarian cancer and microRNA in his study of Oncology.
His research in Incidence intersects with topics in Lung cancer, Postmenopausal women, Epidemiology and Risk factor.
Between 2014 and 2021, his most popular works were:
- A Review of Pulmonary Toxicity of Electronic Cigarettes In The Context of Smoking: A Focus On Inflammation (58 citations)
- Association between dietary inflammatory potential and breast cancer incidence and death: results from the Women's Health Initiative. (51 citations)
- Periodontal Disease and Incident Cancer Risk among Postmenopausal Women: Results from the Women's Health Initiative Observational Cohort. (42 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His scientific interests lie mostly in Breast cancer, Internal medicine, Cancer, Methylation and DNA methylation.
His Breast cancer research is multidisciplinary, incorporating perspectives in Cancer research, Gerontology, Inflammation, Hyperplasia and Physiology.
His Internal medicine research is multidisciplinary, relying on both Endocrinology and Oncology.
His work in Cancer tackles topics such as Prospective cohort study which are related to areas like Cohort study.
In his study, MTHFD1 and Single-nucleotide polymorphism is strongly linked to MTRR, which falls under the umbrella field of Methylation.
His study looks at the relationship between Epidemiology and fields such as Hazard ratio, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
